Ancient herbs meet modern viruses in fight against superbug pneumonia

NCT ID NCT07612605

Not yet recruiting Disease control Sponsor: Chinese PLA General Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-phase trial will test a combination of a Chinese herbal formula (Yiqi Huoxue Jiedu) and bacteriophages (viruses that target bacteria) in 250 people with severe pneumonia caused by drug-resistant bacteria. The goal is to see if this combo can clear the infection faster and reduce deaths. The study is not yet recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Yiqi Huoxue Jiedu formula (herbal mix) and bacteriophages (viruses that kill bacteria)
What this could lead to: If it works, this could point toward a new way to treat severe pneumonia caused by drug-resistant bacteria, potentially lowering death rates.
What could go wrong: This is a very early (Phase 1) trial, so safety and effectiveness are not yet proven. The combination therapy may not work better than standard care, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PNEUMONIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

pneumonia pneumonia caused by gram negative bacteria

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PNEUMONIA

Contacts and locations

Locations

1st Medical Center of Chinese PLA General Hospital

Beijing, China
8th Medical Center of Chinese PLA General Hospital

Beijing, China
The First Affiliated Hospital of Guangzhou Medical University

Guangdong, Guangzhou, China
The First Affiliated Hospital of Guangzhou University of Chinese Medicine

Guangdong, Guangzhou, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.